Literature DB >> 21996055

Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers.

Andrew D Wong1, Matthew A DeWit, Elizabeth R Gillies.   

Abstract

In recent years, numerous delivery systems based on polymers, dendrimers, and nano-scale assemblies have been developed to improve the properties of drug molecules. In general, for the drug molecules to be active, they must be released from these delivery systems, ideally in a selective manner at the therapeutic target. As the changes in physiological conditions are relatively subtle from one tissue to another and the concentrations of specific enzymes are often quite low, a release strategy involving the amplification of a biological signal is particularly attractive. This article describes the development of oligomers, dendrimers, and linear polymers based on self-immolative spacers. This new class of molecules is designed to undergo a cascade of intramolecular reactions in response to the cleavage of a trigger moiety, resulting in molecular fragmentation and the release of multiple reporter or drug molecules. Progress in the development of these materials as drug delivery vehicles and sensors will be highlighted.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21996055     DOI: 10.1016/j.addr.2011.09.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  15 in total

1.  Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.

Authors:  Ying Xie; Tracy Murray-Stewart; Yazhe Wang; Fei Yu; Jing Li; Laurence J Marton; Robert A Casero; David Oupický
Journal:  J Control Release       Date:  2016-12-23       Impact factor: 9.776

Review 2.  Prodrug applications for targeted cancer therapy.

Authors:  Irene Giang; Erin L Boland; Gregory M K Poon
Journal:  AAPS J       Date:  2014-07-09       Impact factor: 4.009

3.  Thermally-Induced Substrate Release Via Intramolecular Cyclizations of Amino Esters and Amino Carbonates.

Authors:  Ralph J Knipp; Rosendo Estrada; Palaniappan Sethu; Michael H Nantz
Journal:  Tetrahedron       Date:  2014-05-01       Impact factor: 2.457

4.  Depolymerizable Poly(O-vinyl carbamate-alt-sulfones) as Customizable Macromolecular Scaffolds for Mucosal Drug Delivery.

Authors:  Kaushlendra Kumar; Eduard Jimenez Castaño; Andrew R Weidner; Adem Yildirim; Andrew P Goodwin
Journal:  ACS Macro Lett       Date:  2016-05-04       Impact factor: 6.903

5.  PEG-Polypeptide Dual Brush Block Copolymers: Synthesis and Application in Nanoparticle Surface PEGylation.

Authors:  Yanfeng Zhang; Qian Yin; Hua Lu; Hongwei Xia; Yao Lin; Jianjun Cheng
Journal:  ACS Macro Lett       Date:  2013-09-17       Impact factor: 6.903

Review 6.  Nanotechnology in cancer therapy.

Authors:  Burcu Aslan; Bulent Ozpolat; Anil K Sood; Gabriel Lopez-Berestein
Journal:  J Drug Target       Date:  2013-09-30       Impact factor: 5.121

7.  Reversible Click Chemistry for Ultrafast and Quantitative Formation of Protein-Polymer Nanoassembly and Intracellular Protein Delivery.

Authors:  Bin Liu; Margareta Ianosi-Irimie; S Thayumanavan
Journal:  ACS Nano       Date:  2019-07-26       Impact factor: 15.881

8.  Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.

Authors:  Jinping Lai; Birju P Shah; Eric Garfunkel; Ki-Bum Lee
Journal:  ACS Nano       Date:  2013-03-11       Impact factor: 15.881

9.  Towards aspirin-inspired self-immolating molecules which target the cyclooxygenases.

Authors:  Christopher R Drake; Luis Estévez-Salmerón; Philippe Gascard; Yang Shen; Thea D Tlsty; Ella F Jones
Journal:  Org Biomol Chem       Date:  2015-09-24       Impact factor: 3.876

10.  Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer.

Authors:  Yu Zhu; Jing Li; Shrey Kanvinde; Zhiyi Lin; Stuart Hazeldine; Rakesh K Singh; David Oupický
Journal:  Mol Pharm       Date:  2014-08-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.